This is similar to the regulation of PPARγ agonist rosiglitazone and metformin on suppressing ILK gene expression in inhibition the growth of CNE1 NPC cells by activation of AMPKα signaling pathway (Hahn et al., 2014). This evidence concerns the gene PPARG and nasopharyngeal carcinoma.